Nucleobase catabolism (Homo sapiens)

From WikiPathways

Revision as of 12:44, 31 October 2018 by ReactomeTeam (Talk | contribs)
Jump to: navigation, search
42, 104, 11113, 24, 76, 81, 89...7, 21, 56, 10371, 73, 8811, 79, 941, 43, 44, 53, 74...71, 8827, 6654, 615146, 48, 681612, 35, 69, 8618, 33, 601719, 36, 56, 75, 84...27, 6630, 32, 59, 10820, 10526, 83, 91, 975, 58, 63, 77, 82...100702, 4, 28, 3710445, 68, 7210422, 4916, 1049, 23, 10118, 33, 6052, 6530, 32, 59, 10810754, 6127, 666, 29, 4110, 24, 40, 76, 81...1008, 9910721, 25, 56, 92, 10314, 50, 10620, 1056739, 47, 7811, 79, 9464, 87, 10955, 1001710024, 34, 8967100703, 5715, 38, 9356, 62, 75, 95, 11030, 31, 80, 94, 96Golgi lumennucleoplasmmitochondrial matrixcytosolendocytic vesicle lumenUraUra-Rib H2OPiXANDNPH1(d)GMP, (d)IMPAMPH2OENTPD1 NUDT1-4 NT5C1BGDP PiThyMg2+ 2DORPUTP,GTP,CTP,dTTPXDH dimerPiH2OH2OAde-Rib, dA,Gua-Rib, InoR5PPiH2OPi2-hydroxy-dAMPR1P ENTPD4 GDA 2M3OPROAdA H2OIDP8-oxo-dGDP(d)C, T, (d)UNTPITPA H2O2-hydroxy-ATPb-AlaUDP CDP GuaU3MP 2-hydroxy-AMPADPNUDT5 dimerdG Ino U2MP H2OCa2+ PiMg2+ 8-hydroxy-dADPPiPiGu-Rib, dG, Ino, dICa2+ GDP H2OAMP H2OdRibP Ura-Rib H+ADP-D-riboseNT5C1A tetramerIno Cyt-Rib DPYS tetramerdU DPYD UMP 5,6-DihydrothymineZn2+ R1P, dRibPCMP NTPNUDT9Gua-Rib dAMP CDP,GDP,UDPThy GMP Cyt-Rib NTPDase7:Ca2+ADPThy-dRib, Ura-Rib,dUNMPCa2+ UPP1 (d)A, (d)G, (d)IH2O2PXLP-AGXT2 NTPDase8:Ca2+,Mg2+CMP NUDT16 dimerENTPD2 ADPRM:Mn2+ENTPD7 SAMHD1:Zn2+ tetramerUPP1, UPP2IMP dRibPdITPPidIMP R1P, dRibPUDP,GDP,CDP,dTDPMPT PiCDP,GDP,IDP,UDPTYMP dimerNT5C3 holoenzyme(d)AMP, (d)GMP,(d)IMPIron Sulphur Cluster Ura-Rib 2-hydroxy-dATPDPYS O2H2OO2NT5C dimerUMP NT5C2 NT5C1A tetramerPiIron Sulphur Cluster Mg2+ dU U2MP NT5C dimerADP,GDP,CDP,IDP,UDPNUDT9-1 CMP GDP Ca2+ 2'-deoxynucleosideTMP Thy-Rib, (d)UMg2+ NH4+AMP PiMg2+ GuaH2OCMP NT5E Thy-dRib H2OPidRibP GMP H2OdAMP Gua-Rib G, dGGPX1 tetramerUra8-oxo-dGMPThy-dRib Pi8-hydroxy-dAMPUTP UMP CTP,GTP,UTPNTPDase6:Ca2+,Mg2+UPROPdU H2ONT5M GMP Mg2+ dIDPOPROPUMP NT5C dG ITPIMPdTTP NUDT1NDPdTDP UDP Mn2+ Gua-Rib dGMP NTPDase2:Ca2+,Mg2+GSHGTP 3AIBIno Pib-AlaThy-dRib Mg2+ H2OENTPD6 (77-484) CMP dU3MP H2ONT5M dimerUPP2 H2OCDP Ca2+ XDH NPTDase5:Ca2+,Mg2+PiUMP H2O5,6-DihydrouracilU3MP ADP NADPHDPYD dimerPidI Ura Ade-RibH2OdA ADPNUDT1 p26 IDP dUMP (d)CMP, TMP, (d)UMPADP GMP dI SAMHD1 dIMPNT5E:Zn2+ dimerITP ADPRM NT5C1A L-selenocysteine residue-GPX1 ENTPD5 NTPDase3:Ca2+,Mg2+UDP dU H2OR1P Ca2+ NT5C2 tetramerAMP, dAMP, GMP, IMPdGTPPiUDP AMP H2OMg2+ NUDT1 p21 GDA dimerH2OMg2+ PiGua-Rib PiL-AlaTMP ADP,GDP,CDP,UDPNTPDase4:Ca2+IMP UTP H2OdNTP(4-)AGXT2 tetramer3AIBCa2+ PiTMP dU GTP UMP dTMP GSSGdUMP CTP ENTPD3 PPiMg2+ H2ONUDT1-2 XTPIMP 8-oxo-dGTPMg2+Zn2+ PidIMP UPB1:Zn2+NH4+AMPH2OH2OH2OUra-Rib Mg2+ Ino UTP UMP FAD UIBAH2OCDP CTP ITPA dimerPYRFAD Mg2+ dC XMPZn2+ Ca2+ H2ONT5C3-4 NT5C NTPDase1:Ca2+,Mg2+CMP,GMP,IMP,UMPAde-Rib dI Thy-dRib NUDT18-1NMPTYMP UDP GMP dG NADP+UPB1 Mg2+ NUDT5 8-oxo-GDPNDPNMPCDP H2ONUDT15PidIMPGMP Cyt-Rib, Thy-dRib,Ura-RibdCMP TMP, U2MP, U3MP,UMP, dU3MP, dUMPADP-RibThy-Rib, dUNDPFMN GDP H2OdGMP Zn2+ PNP PiIno, dIH2OH2OAde-Rib ATP IMP Thy-dRib Ura-Rib NTPPidGMPPiMg2+ GDP UMP,GMP,CMP,dTMPGTP Mg2+ ENTPD8 Zn2+ NT5C1A Mg2+ CO2CMP, TMP, UMPH2OAMP,GMP,CMP,UMPIMPMg2+(d)UraPPiNUDT16 NP trimerCTP dU5MP PiIDP HypATP,GTP,CTP,ITP,UTPR5PAMPTMP, UMP, dU5MP,U2MP, U3MPThy, Ura8-oxo-GMPCDP TMP H2OPPPiurate751075852, 6528, 3714, 505918, 6011615744, 7411672089, 239031, 965913, 909914, 5038, 9345, 726, 291190902735, 86299671


Description

The purine bases guanine and hypoxanthine (derived from adenine by events in the purine salvage pathways) are converted to xanthine and then to uric acid, which is excreted from the body (Watts 1974). The end-point of this pathway in humans and hominoid primates is unusual. Most other mammals metabolize uric acid further to yield more soluble end products, and much speculation has centered on possible roles for high uric acid levels in normal human physiology.

In parallel sequences of three reactions each, the pyrimidines thymine and uracil are converted to beta-aminoisobutyrate and beta-alanine respectively. Both of these molecules are excreted in human urine and appear to be normal end products of pyrimidine catabolism (Griffith 1986). Mitochondrial AGXT2, however, can also catalyze the transamination of both molecules with pyruvate, yielding 2-oxoacids that can be metabolized further by reactions of branched-chain amino acid and short-chain fatty acid catabolism (Tamaki et al. 2000).<p>Hydrolysis of phosphate bonds in nucleotides catalyzed by members of the NUDT and NTPD families of enzymes have been grouped here as well, although the physiological roles of these groups of catabolic reactions are diverse. View original pathway at:Reactome.</div>

Comments

Reactome-Converter 
Pathway is converted from Reactome ID: 8956319
Reactome-version 
Reactome version: 62
Reactome Author 
Reactome Author: Jassal, Bijay

Try the New WikiPathways

View approved pathways at the new wikipathways.org.

Quality Tags

Ontology Terms

 

Bibliography

View all...
  1. Oda H, Taketomi A, Maruyama R, Itoh R, Nishioka K, Yakushiji H, Suzuki T, Sekiguchi M, Nakabeppu Y.; ''Multi-forms of human MTH1 polypeptides produced by alternative translation initiation and single nucleotide polymorphism.''; PubMed Europe PMC Scholia
  2. Gazziola C, Ferraro P, Moras M, Reichard P, Bianchi V.; ''Cytosolic high K(m) 5'-nucleotidase and 5'(3')-deoxyribonucleotidase in substrate cycles involved in nucleotide metabolism.''; PubMed Europe PMC Scholia
  3. Goldstone DC, Ennis-Adeniran V, Hedden JJ, Groom HC, Rice GI, Christodoulou E, Walker PA, Kelly G, Haire LF, Yap MW, de Carvalho LP, Stoye JP, Crow YJ, Taylor IA, Webb M.; ''HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase.''; PubMed Europe PMC Scholia
  4. Spychała J, Madrid-Marina V, Fox IH.; ''High Km soluble 5'-nucleotidase from human placenta. Properties and allosteric regulation by IMP and ATP.''; PubMed Europe PMC Scholia
  5. Enjyoji K, Sévigny J, Lin Y, Frenette PS, Christie PD, Esch JS, Imai M, Edelberg JM, Rayburn H, Lech M, Beeler DL, Csizmadia E, Wagner DD, Robson SC, Rosenberg RD.; ''Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation.''; PubMed Europe PMC Scholia
  6. Walldén K, Stenmark P, Nyman T, Flodin S, Gräslund S, Loppnau P, Bianchi V, Nordlund P.; ''Crystal structure of human cytosolic 5'-nucleotidase II: insights into allosteric regulation and substrate recognition.''; PubMed Europe PMC Scholia
  7. Belcher SM, Zsarnovszky A, Crawford PA, Hemani H, Spurling L, Kirley TL.; ''Immunolocalization of ecto-nucleoside triphosphate diphosphohydrolase 3 in rat brain: implications for modulation of multiple homeostatic systems including feeding and sleep-wake behaviors.''; PubMed Europe PMC Scholia
  8. Misumi Y, Ogata S, Ohkubo K, Hirose S, Ikehara Y.; ''Primary structure of human placental 5'-nucleotidase and identification of the glycolipid anchor in the mature form.''; PubMed Europe PMC Scholia
  9. Williams SR, Gekeler V, McIvor RS, Martin DW.; ''A human purine nucleoside phosphorylase deficiency caused by a single base change.''; PubMed Europe PMC Scholia
  10. Failer BU, Aschrafi A, Schmalzing G, Zimmermann H.; ''Determination of native oligomeric state and substrate specificity of rat NTPDase1 and NTPDase2 after heterologous expression in Xenopus oocytes.''; PubMed Europe PMC Scholia
  11. Mulero JJ, Yeung G, Nelken ST, Bright JM, McGowan DW, Ford JE.; ''Biochemical characterization of CD39L4.''; PubMed Europe PMC Scholia
  12. Shi JD, Kukar T, Wang CY, Li QZ, Cruz PE, Davoodi-Semiromi A, Yang P, Gu Y, Lian W, Wu DH, She JX.; ''Molecular cloning and characterization of a novel mammalian endo-apyrase (LALP1).''; PubMed Europe PMC Scholia
  13. Murphy PM, Bolduc JM, Gallaher JL, Stoddard BL, Baker D.; ''Alteration of enzyme specificity by computational loop remodeling and design.''; PubMed Europe PMC Scholia
  14. Lemmens R, Vanduffel L, Kittel A, Beaudoin AR, Benrezzak O, Sévigny J.; ''Distribution, cloning, and characterization of porcine nucleoside triphosphate diphosphohydrolase-1.''; PubMed Europe PMC Scholia
  15. Sakai Y, Furuichi M, Takahashi M, Mishima M, Iwai S, Shirakawa M, Nakabeppu Y.; ''A molecular basis for the selective recognition of 2-hydroxy-dATP and 8-oxo-dGTP by human MTH1.''; PubMed Europe PMC Scholia
  16. Zimmermann H.; ''5'-Nucleotidase: molecular structure and functional aspects.''; PubMed Europe PMC Scholia
  17. Gallinaro L, Crovatto K, Rampazzo C, Pontarin G, Ferraro P, Milanesi E, Reichard P, Bianchi V.; ''Human mitochondrial 5'-deoxyribonucleotidase. Overproduction in cultured cells and functional aspects.''; PubMed Europe PMC Scholia
  18. Hicks-Berger CA, Chadwick BP, Frischauf AM, Kirley TL.; ''Expression and characterization of soluble and membrane-bound human nucleoside triphosphate diphosphohydrolase 6 (CD39L2).''; PubMed Europe PMC Scholia
  19. Abolhassani N, Iyama T, Tsuchimoto D, Sakumi K, Ohno M, Behmanesh M, Nakabeppu Y.; ''NUDT16 and ITPA play a dual protective role in maintaining chromosome stability and cell growth by eliminating dIDP/IDP and dITP/ITP from nucleotide pools in mammals.''; PubMed Europe PMC Scholia
  20. Roosild TP, Castronovo S, Fabbiani M, Pizzorno G.; ''Implications of the structure of human uridine phosphorylase 1 on the development of novel inhibitors for improving the therapeutic window of fluoropyrimidine chemotherapy.''; PubMed Europe PMC Scholia
  21. Shen Z, Huang S, Fang M, Wang X.; ''ENTPD5, an endoplasmic reticulum UDPase, alleviates ER stress induced by protein overloading in AKT-activated cancer cells.''; PubMed Europe PMC Scholia
  22. Yuan G, Bin JC, McKay DJ, Snyder FF.; ''Cloning and characterization of human guanine deaminase. Purification and partial amino acid sequence of the mouse protein.''; PubMed Europe PMC Scholia
  23. Wiginton DA, Coleman MS, Hutton JJ.; ''Characterization of purine nucleoside phosphorylase from human granulocytes and its metabolism of deoxyribonucleosides.''; PubMed Europe PMC Scholia
  24. Kegel B, Braun N, Heine P, Maliszewski CR, Zimmermann H.; ''An ecto-ATPase and an ecto-ATP diphosphohydrolase are expressed in rat brain.''; PubMed Europe PMC Scholia
  25. Yan J, Kaur S, DeLucia M, Hao C, Mehrens J, Wang C, Golczak M, Palczewski K, Gronenborn AM, Ahn J, Skowronski J.; ''Tetramerization of SAMHD1 is required for biological activity and inhibition of HIV infection.''; PubMed Europe PMC Scholia
  26. Ivanenkov VV, Murphy-Piedmonte DM, Kirley TL.; ''Bacterial expression, characterization, and disulfide bond determination of soluble human NTPDase6 (CD39L2) nucleotidase: implications for structure and function.''; PubMed Europe PMC Scholia
  27. Yeung G, Mulero JJ, McGowan DW, Bajwa SS, Ford JE.; ''CD39L2, a gene encoding a human nucleoside diphosphatase, predominantly expressed in the heart.''; PubMed Europe PMC Scholia
  28. Usuki K, Saras J, Waltenberger J, Miyazono K, Pierce G, Thomason A, Heldin CH.; ''Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity.''; PubMed Europe PMC Scholia
  29. Lavoie EG, Fausther M, Kauffenstein G, Kukulski F, Künzli BM, Friess H, Sévigny J.; ''Identification of the ectonucleotidases expressed in mouse, rat, and human Langerhans islets: potential role of NTPDase3 in insulin secretion.''; PubMed Europe PMC Scholia
  30. Shen BW, Perraud AL, Scharenberg A, Stoddard BL.; ''The crystal structure and mutational analysis of human NUDT9.''; PubMed Europe PMC Scholia
  31. Desgranges C, Razaka G, Rabaud M, Bricaud H.; ''Catabolism of thymidine in human blood platelets: purification and properties of thymidine phosphorylase.''; PubMed Europe PMC Scholia
  32. Iyama T, Abolhassani N, Tsuchimoto D, Nonaka M, Nakabeppu Y.; ''NUDT16 is a (deoxy)inosine diphosphatase, and its deficiency induces accumulation of single-strand breaks in nuclear DNA and growth arrest.''; PubMed Europe PMC Scholia
  33. Skladanowski AC, Newby AC.; ''Partial purification and properties of an AMP-specific soluble 5'-nucleotidase from pigeon heart.''; PubMed Europe PMC Scholia
  34. Kauffenstein G, Drouin A, Thorin-Trescases N, Bachelard H, Robaye B, D'Orléans-Juste P, Marceau F, Thorin E, Sévigny J.; ''NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse.''; PubMed Europe PMC Scholia
  35. Ito R, Sekiguchi M, Setoyama D, Nakatsu Y, Yamagata Y, Hayakawa H.; ''Cleavage of oxidized guanine nucleotide and ADP sugar by human NUDT5 protein.''; PubMed Europe PMC Scholia
  36. Kukulski F, Lévesque SA, Sévigny J.; ''Impact of ectoenzymes on p2 and p1 receptor signaling.''; PubMed Europe PMC Scholia
  37. Griffith OW.; ''Beta-amino acids: mammalian metabolism and utility as alpha-amino acid analogues.''; PubMed Europe PMC Scholia
  38. Amici A, Magni G.; ''Human erythrocyte pyrimidine 5'-nucleotidase, PN-I.''; PubMed Europe PMC Scholia
  39. Saksela M, Raivio KO.; ''Cloning and expression in vitro of human xanthine dehydrogenase/oxidase.''; PubMed Europe PMC Scholia
  40. Marcus AJ, Broekman MJ, Drosopoulos JH, Islam N, Pinsky DJ, Sesti C, Levi R.; ''Heterologous cell-cell interactions: thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase-1).''; PubMed Europe PMC Scholia
  41. Watts RW.; ''Molecular variation in relation to purine metabolism.''; PubMed Europe PMC Scholia
  42. Cho CS, Lee S, Lee GT, Woo HA, Choi EJ, Rhee SG.; ''Irreversible inactivation of glutathione peroxidase 1 and reversible inactivation of peroxiredoxin II by H2O2 in red blood cells.''; PubMed Europe PMC Scholia
  43. Thompson LF, Ruedi JM, Low MG.; ''Purification of 5'-nucleotidase from human placenta after release from plasma membranes by phosphatidylinositol-specific phospholipase C.''; PubMed Europe PMC Scholia
  44. Hunsucker SA, Spychala J, Mitchell BS.; ''Human cytosolic 5'-nucleotidase I: characterization and role in nucleoside analog resistance.''; PubMed Europe PMC Scholia
  45. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, Chen JF, Enjyoji K, Linden J, Oukka M, Kuchroo VK, Strom TB, Robson SC.; ''Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.''; PubMed Europe PMC Scholia
  46. Sala-Newby GB, Freeman NV, Skladanowski AC, Newby AC.; ''Distinct roles for recombinant cytosolic 5'-nucleotidase-I and -II in AMP and IMP catabolism in COS-7 and H9c2 rat myoblast cell lines.''; PubMed Europe PMC Scholia
  47. Amiable C, Pochet S, Padilla A, Labesse G, Kaminski PA.; ''N (6)-substituted AMPs inhibit mammalian deoxynucleotide N-hydrolase DNPH1.''; PubMed Europe PMC Scholia
  48. Rodionov RN, Murry DJ, Vaulman SF, Stevens JW, Lentz SR.; ''Human alanine-glyoxylate aminotransferase 2 lowers asymmetric dimethylarginine and protects from inhibition of nitric oxide production.''; PubMed Europe PMC Scholia
  49. Fang M, Shen Z, Huang S, Zhao L, Chen S, Mak TW, Wang X.; ''The ER UDPase ENTPD5 promotes protein N-glycosylation, the Warburg effect, and proliferation in the PTEN pathway.''; PubMed Europe PMC Scholia
  50. Cabezas A, Ribeiro JM, Rodrigues JR, López-Villamizar I, Fernández A, Canales J, Pinto RM, Costas MJ, Cameselle JC.; ''Molecular bases of catalysis and ADP-ribose preference of human Mn2+-dependent ADP-ribose/CDP-alcohol diphosphatase and conversion by mutagenesis to a preferential cyclic ADP-ribose phosphohydrolase.''; PubMed Europe PMC Scholia
  51. Sala-Newby GB, Freeman NV, Curto MA, Newby AC.; ''Metabolic and functional consequences of cytosolic 5'-nucleotidase-IA overexpression in neonatal rat cardiomyocytes.''; PubMed Europe PMC Scholia
  52. Stone CD.; ''The importance of having a mentor, and how to find one.''; PubMed Europe PMC Scholia
  53. Rampazzo C, Gallinaro L, Milanesi E, Frigimelica E, Reichard P, Bianchi V.; ''A deoxyribonucleotidase in mitochondria: involvement in regulation of dNTP pools and possible link to genetic disease.''; PubMed Europe PMC Scholia
  54. Zha M, Zhong C, Peng Y, Hu H, Ding J.; ''Crystal structures of human NUDT5 reveal insights into the structural basis of the substrate specificity.''; PubMed Europe PMC Scholia
  55. Hamajima N, Kouwaki M, Vreken P, Matsuda K, Sumi S, Imaeda M, Ohba S, Kidouchi K, Nonaka M, Sasaki M, Tamaki N, Endo Y, De Abreu R, Rotteveel J, van Kuilenburg A, van Gennip A, Togari H, Wada Y.; ''Dihydropyrimidinase deficiency: structural organization, chromosomal localization, and mutation analysis of the human dihydropyrimidinase gene.''; PubMed Europe PMC Scholia
  56. Zhu C, Gao W, Zhao K, Qin X, Zhang Y, Peng X, Zhang L, Dong Y, Zhang W, Li P, Wei W, Gong Y, Yu XF.; ''Structural insight into dGTP-dependent activation of tetrameric SAMHD1 deoxynucleoside triphosphate triphosphohydrolase.''; PubMed Europe PMC Scholia
  57. Rees DC, Duley JA, Marinaki AM.; ''Pyrimidine 5' nucleotidase deficiency.''; PubMed Europe PMC Scholia
  58. Awasthi YC, Beutler E, Srivastava SK.; ''Purification and properties of human erythrocyte glutathione peroxidase.''; PubMed Europe PMC Scholia
  59. Sala-Newby GB, Newby AC.; ''Cloning of a mouse cytosolic 5'-nucleotidase-I identifies a new gene related to human autoimmune infertility-related protein.''; PubMed Europe PMC Scholia
  60. Mateo J, Harden TK, Boyer JL.; ''Functional expression of a cDNA encoding a human ecto-ATPase.''; PubMed Europe PMC Scholia
  61. Peculis BA, Reynolds K, Cleland M.; ''Metal determines efficiency and substrate specificity of the nuclear NUDIX decapping proteins X29 and H29K (Nudt16).''; PubMed Europe PMC Scholia
  62. Thompson LF, Ruedi JM, Low MG, Clement LT.; ''Distribution of ecto-5'-nucleotidase on subsets of human T and B lymphocytes as detected by indirect immunofluorescence using goat antibodies.''; PubMed Europe PMC Scholia
  63. Vorhoff T, Zimmermann H, Pelletier J, Sévigny J, Braun N.; ''Cloning and characterization of the ecto-nucleotidase NTPDase3 from rat brain: Predicted secondary structure and relation to other members of the E-NTPDase family and actin.''; PubMed Europe PMC Scholia
  64. Kukulski F, Lévesque SA, Lavoie EG, Lecka J, Bigonnesse F, Knowles AF, Robson SC, Kirley TL, Sévigny J.; ''Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8.''; PubMed Europe PMC Scholia
  65. Rampazzo C, Johansson M, Gallinaro L, Ferraro P, Hellman U, Karlsson A, Reichard P, Bianchi V.; ''Mammalian 5'(3')-deoxyribonucleotidase, cDNA cloning, and overexpression of the enzyme in Escherichia coli and mammalian cells.''; PubMed Europe PMC Scholia
  66. Tamaki N, Sakata SF, Matsuda K.; ''Purification, properties, and sequencing of aminoisobutyrate aminotransferases from rat liver.''; PubMed Europe PMC Scholia
  67. Zha M, Guo Q, Zhang Y, Yu B, Ou Y, Zhong C, Ding J.; ''Molecular mechanism of ADP-ribose hydrolysis by human NUDT5 from structural and kinetic studies.''; PubMed Europe PMC Scholia
  68. Takahashi K, Newburger PE, Cohen HJ.; ''Glutathione peroxidase protein. Absence in selenium deficiency states and correlation with enzymatic activity.''; PubMed Europe PMC Scholia
  69. Kang D, Nishida J, Iyama A, Nakabeppu Y, Furuichi M, Fujiwara T, Sekiguchi M, Takeshige K.; ''Intracellular localization of 8-oxo-dGTPase in human cells, with special reference to the role of the enzyme in mitochondria.''; PubMed Europe PMC Scholia
  70. van Kuilenburg AB, Meinsma R, Beke E, Assmann B, Ribes A, Lorente I, Busch R, Mayatepek E, Abeling NG, van Cruchten A, Stroomer AE, van Lenthe H, Zoetekouw L, Kulik W, Hoffmann GF, Voit T, Wevers RA, Rutsch F, van Gennip AH.; ''beta-Ureidopropionase deficiency: an inborn error of pyrimidine degradation associated with neurological abnormalities.''; PubMed Europe PMC Scholia
  71. Chu FF, Doroshow JH, Esworthy RS.; ''Expression, characterization, and tissue distribution of a new cellular selenium-dependent glutathione peroxidase, GSHPx-GI.''; PubMed Europe PMC Scholia
  72. Kirley TL.; ''Complementary DNA cloning and sequencing of the chicken muscle ecto-ATPase. Homology with the lymphoid cell activation antigen CD39.''; PubMed Europe PMC Scholia
  73. Ealick SE, Rule SA, Carter DC, Greenhough TJ, Babu YS, Cook WJ, Habash J, Helliwell JR, Stoeckler JD, Parks RE.; ''Three-dimensional structure of human erythrocytic purine nucleoside phosphorylase at 3.2 A resolution.''; PubMed Europe PMC Scholia
  74. Kusu T, Kayama H, Kinoshita M, Jeon SG, Ueda Y, Goto Y, Okumura R, Saiga H, Kurakawa T, Ikeda K, Maeda Y, Nishimura J, Arima Y, Atarashi K, Honda K, Murakami M, Kunisawa J, Kiyono H, Okumura M, Yamamoto M, Takeda K.; ''Ecto-nucleoside triphosphate diphosphohydrolase 7 controls Th17 cell responses through regulation of luminal ATP in the small intestine.''; PubMed Europe PMC Scholia
  75. Perraud AL, Shen B, Dunn CA, Rippe K, Smith MK, Bessman MJ, Stoddard BL, Scharenberg AM.; ''NUDT9, a member of the Nudix hydrolase family, is an evolutionarily conserved mitochondrial ADP-ribose pyrophosphatase.''; PubMed Europe PMC Scholia
  76. Fujikawa K, Kamiya H, Yakushiji H, Nakabeppu Y, Kasai H.; ''Human MTH1 protein hydrolyzes the oxidized ribonucleotide, 2-hydroxy-ATP.''; PubMed Europe PMC Scholia
  77. Sala-Newby GB, Skladanowski AC, Newby AC.; ''The mechanism of adenosine formation in cells. Cloning of cytosolic 5'-nucleotidase-I.''; PubMed Europe PMC Scholia
  78. Mulero JJ, Yeung G, Nelken ST, Ford JE.; ''CD39-L4 is a secreted human apyrase, specific for the hydrolysis of nucleoside diphosphates.''; PubMed Europe PMC Scholia
  79. Kaczmarek E, Koziak K, Sévigny J, Siegel JB, Anrather J, Beaudoin AR, Bach FH, Robson SC.; ''Identification and characterization of CD39/vascular ATP diphosphohydrolase.''; PubMed Europe PMC Scholia
  80. Watanabe S, Uchida T.; ''Cloning and expression of human uridine phosphorylase.''; PubMed Europe PMC Scholia
  81. Huber KV, Salah E, Radic B, Gridling M, Elkins JM, Stukalov A, Jemth AS, Göktürk C, Sanjiv K, Strömberg K, Pham T, Berglund UW, Colinge J, Bennett KL, Loizou JI, Helleday T, Knapp S, Superti-Furga G.; ''Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy.''; PubMed Europe PMC Scholia
  82. Fausther M, Lecka J, Kukulski F, Lévesque SA, Pelletier J, Zimmermann H, Dranoff JA, Sévigny J.; ''Cloning, purification, and identification of the liver canalicular ecto-ATPase as NTPDase8.''; PubMed Europe PMC Scholia
  83. Ghiorghi YK, Zeller KI, Dang CV, Kaminski PA.; ''The c-Myc target gene Rcl (C6orf108) encodes a novel enzyme, deoxynucleoside 5'-monophosphate N-glycosidase.''; PubMed Europe PMC Scholia
  84. Rinaldo-Matthis A, Rampazzo C, Reichard P, Bianchi V, Nordlund P.; ''Crystal structure of a human mitochondrial deoxyribonucleotidase.''; PubMed Europe PMC Scholia
  85. Amiable C, Paoletti J, Haouz A, Padilla A, Labesse G, Kaminski PA, Pochet S.; ''6-(Hetero)Arylpurine nucleotides as inhibitors of the oncogenic target DNPH1: synthesis, structural studies and cytotoxic activities.''; PubMed Europe PMC Scholia
  86. Cai JP, Ishibashi T, Takagi Y, Hayakawa H, Sekiguchi M.; ''Mouse MTH2 protein which prevents mutations caused by 8-oxoguanine nucleotides.''; PubMed Europe PMC Scholia
  87. Wang TF, Guidotti G.; ''Golgi localization and functional expression of human uridine diphosphatase.''; PubMed Europe PMC Scholia
  88. Sakumi K, Furuichi M, Tsuzuki T, Kakuma T, Kawabata S, Maki H, Sekiguchi M.; ''Cloning and expression of cDNA for a human enzyme that hydrolyzes 8-oxo-dGTP, a mutagenic substrate for DNA synthesis.''; PubMed Europe PMC Scholia
  89. Sévigny J, Robson SC, Waelkens E, Csizmadia E, Smith RN, Lemmens R.; ''Identification and characterization of a novel hepatic canalicular ATP diphosphohydrolase.''; PubMed Europe PMC Scholia
  90. Mishima M, Sakai Y, Itoh N, Kamiya H, Furuichi M, Takahashi M, Yamagata Y, Iwai S, Nakabeppu Y, Shirakawa M.; ''Structure of human MTH1, a Nudix family hydrolase that selectively degrades oxidized purine nucleoside triphosphates.''; PubMed Europe PMC Scholia
  91. Norman RA, Barry ST, Bate M, Breed J, Colls JG, Ernill RJ, Luke RW, Minshull CA, McAlister MS, McCall EJ, McMiken HH, Paterson DS, Timms D, Tucker JA, Pauptit RA.; ''Crystal structure of human thymidine phosphorylase in complex with a small molecule inhibitor.''; PubMed Europe PMC Scholia
  92. Gad H, Koolmeister T, Jemth AS, Eshtad S, Jacques SA, Ström CE, Svensson LM, Schultz N, Lundbäck T, Einarsdottir BO, Saleh A, Göktürk C, Baranczewski P, Svensson R, Berntsson RP, Gustafsson R, Strömberg K, Sanjiv K, Jacques-Cordonnier MC, Desroses M, Gustavsson AL, Olofsson R, Johansson F, Homan EJ, Loseva O, Bräutigam L, Johansson L, Höglund A, Hagenkort A, Pham T, Altun M, Gaugaz FZ, Vikingsson S, Evers B, Henriksson M, Vallin KS, Wallner OA, Hammarström LG, Wiita E, Almlöf I, Kalderén C, Axelsson H, Djureinovic T, Puigvert JC, Häggblad M, Jeppsson F, Martens U, Lundin C, Lundgren B, Granelli I, Jensen AJ, Artursson P, Nilsson JA, Stenmark P, Scobie M, Berglund UW, Helleday T.; ''MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool.''; PubMed Europe PMC Scholia
  93. Johansson M.; ''Identification of a novel human uridine phosphorylase.''; PubMed Europe PMC Scholia
  94. Sévigny J, Sundberg C, Braun N, Guckelberger O, Csizmadia E, Qawi I, Imai M, Zimmermann H, Robson SC.; ''Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation.''; PubMed Europe PMC Scholia
  95. Franzolin E, Pontarin G, Rampazzo C, Miazzi C, Ferraro P, Palumbo E, Reichard P, Bianchi V.; ''The deoxynucleotide triphosphohydrolase SAMHD1 is a major regulator of DNA precursor pools in mammalian cells.''; PubMed Europe PMC Scholia
  96. Amici A, Emanuelli M, Magni G, Raffaelli N, Ruggieri S.; ''Pyrimidine nucleotidases from human erythrocyte possess phosphotransferase activities specific for pyrimidine nucleotides.''; PubMed Europe PMC Scholia
  97. Smith TM, Kirley TL.; ''Cloning, sequencing, and expression of a human brain ecto-apyrase related to both the ecto-ATPases and CD39 ecto-apyrases1.''; PubMed Europe PMC Scholia
  98. Yoshimura D, Sakumi K, Ohno M, Sakai Y, Furuichi M, Iwai S, Nakabeppu Y.; ''An oxidized purine nucleoside triphosphatase, MTH1, suppresses cell death caused by oxidative stress.''; PubMed Europe PMC Scholia
  99. Bianchi V, Spychala J.; ''Mammalian 5'-nucleotidases.''; PubMed Europe PMC Scholia
  100. Marinaki AM, Escuredo E, Duley JA, Simmonds HA, Amici A, Naponelli V, Magni G, Seip M, Ben-Bassat I, Harley EH, Thein SL, Rees DC.; ''Genetic basis of hemolytic anemia caused by pyrimidine 5' nucleotidase deficiency.''; PubMed Europe PMC Scholia
  101. Powell RD, Holland PJ, Hollis T, Perrino FW.; ''Aicardi-Goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase.''; PubMed Europe PMC Scholia
  102. Höglund L, Reichard P.; ''Cytoplasmic 5'(3')-nucleotidase from human placenta.''; PubMed Europe PMC Scholia
  103. Rice GI, Bond J, Asipu A, Brunette RL, Manfield IW, Carr IM, Fuller JC, Jackson RM, Lamb T, Briggs TA, Ali M, Gornall H, Couthard LR, Aeby A, Attard-Montalto SP, Bertini E, Bodemer C, Brockmann K, Brueton LA, Corry PC, Desguerre I, Fazzi E, Cazorla AG, Gener B, Hamel BC, Heiberg A, Hunter M, Hunter M, van der Knaap MS, Kumar R, Lagae L, Landrieu PG, Lourenco CM, Marom D, McDermott MF, van der Merwe W, Orcesi S, Prendiville JS, Rasmussen M, Shalev SA, Soler DM, Shinawi M, Spiegel R, Tan TY, Vanderver A, Wakeling EL, Wassmer E, Whittaker E, Lebon P, Stetson DB, Bonthron DT, Crow YJ.; ''Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response.''; PubMed Europe PMC Scholia
  104. Mizumoto N, Kumamoto T, Robson SC, Sévigny J, Matsue H, Enjyoji K, Takashima A.; ''CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness.''; PubMed Europe PMC Scholia
  105. Lavoie EG, Kukulski F, Lévesque SA, Lecka J, Sévigny J.; ''Cloning and characterization of mouse nucleoside triphosphate diphosphohydrolase-3.''; PubMed Europe PMC Scholia
  106. Mateo J, Kreda S, Henry CE, Harden TK, Boyer JL.; ''Requirement of Cys399 for processing of the human ecto-ATPase (NTPDase2) and its implications for determination of the activities of splice variants of the enzyme.''; PubMed Europe PMC Scholia
  107. Bigonnesse F, Lévesque SA, Kukulski F, Lecka J, Robson SC, Fernandes MJ, Sévigny J.; ''Cloning and characterization of mouse nucleoside triphosphate diphosphohydrolase-8.''; PubMed Europe PMC Scholia
  108. Yamaguchi Y, Matsumura T, Ichida K, Okamoto K, Nishino T.; ''Human xanthine oxidase changes its substrate specificity to aldehyde oxidase type upon mutation of amino acid residues in the active site: roles of active site residues in binding and activation of purine substrate.''; PubMed Europe PMC Scholia
  109. Yokota H, Fernandez-Salguero P, Furuya H, Lin K, McBride OW, Podschun B, Schnackerz KD, Gonzalez FJ.; ''cDNA cloning and chromosome mapping of human dihydropyrimidine dehydrogenase, an enzyme associated with 5-fluorouracil toxicity and congenital thymine uraciluria.''; PubMed Europe PMC Scholia
  110. Fujikawa K, Kamiya H, Yakushiji H, Fujii Y, Nakabeppu Y, Kasai H.; ''The oxidized forms of dATP are substrates for the human MutT homologue, the hMTH1 protein.''; PubMed Europe PMC Scholia
  111. Lin S, McLennan AG, Ying K, Wang Z, Gu S, Jin H, Wu C, Liu W, Yuan Y, Tang R, Xie Y, Mao Y.; ''Cloning, expression, and characterization of a human inosine triphosphate pyrophosphatase encoded by the itpa gene.''; PubMed Europe PMC Scholia
  112. Takagi Y, Setoyama D, Ito R, Kamiya H, Yamagata Y, Sekiguchi M.; ''Human MTH3 (NUDT18) protein hydrolyzes oxidized forms of guanosine and deoxyguanosine diphosphates: comparison with MTH1 and MTH2.''; PubMed Europe PMC Scholia

History

View all...
CompareRevisionActionTimeUserComment
114902view16:41, 25 January 2021ReactomeTeamReactome version 75
113347view11:42, 2 November 2020ReactomeTeamReactome version 74
112556view15:52, 9 October 2020ReactomeTeamReactome version 73
101470view11:33, 1 November 2018ReactomeTeamreactome version 66
101008view21:13, 31 October 2018ReactomeTeamreactome version 65
100544view19:47, 31 October 2018ReactomeTeamreactome version 64
100092view16:31, 31 October 2018ReactomeTeamreactome version 63
99642view15:03, 31 October 2018ReactomeTeamreactome version 62 (2nd attempt)
99244view12:44, 31 October 2018ReactomeTeamreactome version 62
93283view11:19, 9 August 2017ReactomeTeamNew pathway

External references

DataNodes

View all...
NameTypeDatabase referenceComment
(d)A, (d)G, (d)IComplexR-ALL-500124 (Reactome)
(d)AMP, (d)GMP, (d)IMPComplexR-ALL-500125 (Reactome)
(d)C, T, (d)UComplexR-ALL-500346 (Reactome)
(d)CMP, TMP, (d)UMPComplexR-ALL-500347 (Reactome)
(d)GMP, (d)IMPComplexR-ALL-500120 (Reactome)
(d)UraComplexR-ALL-500430 (Reactome)
2'-deoxynucleosideMetaboliteCHEBI:18274 (ChEBI)
2-hydroxy-AMPMetaboliteCHEBI:65129 (ChEBI)
2-hydroxy-ATPMetaboliteCHEBI:65119 (ChEBI)
2-hydroxy-dAMPMetaboliteCHEBI:63211 (ChEBI)
2-hydroxy-dATPMetaboliteCHEBI:63208 (ChEBI)
2DORPMetaboliteCHEBI:19569 (ChEBI)
2M3OPROAMetaboliteCHEBI:16256 (ChEBI)
3AIBMetaboliteCHEBI:16320 (ChEBI)
5,6-DihydrothymineMetaboliteCHEBI:27468 (ChEBI)
5,6-DihydrouracilMetaboliteCHEBI:15901 (ChEBI)
8-hydroxy-dADPMetaboliteCHEBI:70963 (ChEBI)
8-hydroxy-dAMPMetaboliteCHEBI:70964 (ChEBI)
8-oxo-GDPMetaboliteCHEBI:65134 (ChEBI)
8-oxo-GMPMetaboliteCHEBI:65135 (ChEBI)
8-oxo-dGDPMetaboliteCHEBI:63728 (ChEBI)
8-oxo-dGMPMetaboliteCHEBI:63223 (ChEBI)
8-oxo-dGTPMetaboliteCHEBI:63220 (ChEBI)
ADP MetaboliteCHEBI:16761 (ChEBI)
ADP,GDP,CDP,IDP,UDPComplexR-ALL-8851092 (Reactome)
ADP,GDP,CDP,UDPComplexR-ALL-8936165 (Reactome)
ADP-D-riboseMetaboliteCHEBI:16960 (ChEBI)
ADP-RibMetaboliteCHEBI:16960 (ChEBI)
ADPMetaboliteCHEBI:16761 (ChEBI)
ADPRM ProteinQ3LIE5 (Uniprot-TrEMBL)
ADPRM:Mn2+ComplexR-HSA-5696039 (Reactome)
AGXT2 tetramerComplexR-HSA-904854 (Reactome)
AMP MetaboliteCHEBI:16027 (ChEBI)
AMP, dAMP, GMP, IMPComplexR-ALL-500101 (Reactome)
AMP,GMP,CMP,UMPComplexR-ALL-8851369 (Reactome)
AMPMetaboliteCHEBI:16027 (ChEBI)
ATP MetaboliteCHEBI:15422 (ChEBI)
ATP,GTP,CTP,ITP,UTPComplexR-ALL-8936166 (Reactome)
Ade-Rib MetaboliteCHEBI:16335 (ChEBI)
Ade-Rib, dA, Gua-Rib, InoComplexR-ALL-500104 (Reactome)
Ade-RibMetaboliteCHEBI:16335 (ChEBI)
CDP MetaboliteCHEBI:17239 (ChEBI)
CDP,GDP,IDP,UDPComplexR-ALL-8851462 (Reactome)
CDP,GDP,UDPComplexR-ALL-8851518 (Reactome)
CMP MetaboliteCHEBI:17361 (ChEBI)
CMP, TMP, UMPComplexR-ALL-500316 (Reactome)
CMP,GMP,IMP,UMPComplexR-ALL-8851461 (Reactome)
CO2MetaboliteCHEBI:16526 (ChEBI)
CTP MetaboliteCHEBI:17677 (ChEBI)
CTP,GTP,UTPComplexR-ALL-8851509 (Reactome)
Ca2+ MetaboliteCHEBI:29108 (ChEBI)
Cyt-Rib MetaboliteCHEBI:17562 (ChEBI)
Cyt-Rib, Thy-dRib, Ura-RibComplexR-ALL-500318 (Reactome)
DNPH1ProteinO43598 (Uniprot-TrEMBL)
DPYD ProteinQ12882 (Uniprot-TrEMBL)
DPYD dimerComplexR-HSA-73529 (Reactome)
DPYS ProteinQ14117 (Uniprot-TrEMBL)
DPYS tetramerComplexR-HSA-73468 (Reactome)
ENTPD1 ProteinP49961 (Uniprot-TrEMBL)
ENTPD2 ProteinQ9Y5L3 (Uniprot-TrEMBL)
ENTPD3 ProteinO75355 (Uniprot-TrEMBL)
ENTPD4 ProteinQ9Y227 (Uniprot-TrEMBL)
ENTPD5 ProteinO75356 (Uniprot-TrEMBL)
ENTPD6 (77-484) ProteinO75354 (Uniprot-TrEMBL)
ENTPD7 ProteinQ9NQZ7 (Uniprot-TrEMBL)
ENTPD8 ProteinQ5MY95 (Uniprot-TrEMBL)
FAD MetaboliteCHEBI:16238 (ChEBI)
FMN MetaboliteCHEBI:17621 (ChEBI)
G, dGComplexR-ALL-500245 (Reactome)
GDA ProteinQ9Y2T3 (Uniprot-TrEMBL)
GDA dimerComplexR-HSA-74253 (Reactome)
GDP MetaboliteCHEBI:17552 (ChEBI)
GMP MetaboliteCHEBI:17345 (ChEBI)
GPX1 tetramerComplexR-HSA-71674 (Reactome)
GSHMetaboliteCHEBI:16856 (ChEBI)
GSSGMetaboliteCHEBI:17858 (ChEBI)
GTP MetaboliteCHEBI:15996 (ChEBI)
Gu-Rib, dG, Ino, dIComplexR-ALL-500118 (Reactome)
Gua-Rib MetaboliteCHEBI:16750 (ChEBI)
GuaMetaboliteCHEBI:16235 (ChEBI)
H+MetaboliteCHEBI:15378 (ChEBI)
H2O2MetaboliteCHEBI:16240 (ChEBI)
H2OMetaboliteCHEBI:15377 (ChEBI)
HypMetaboliteCHEBI:17368 (ChEBI)
IDP MetaboliteCHEBI:17808 (ChEBI)
IDPMetaboliteCHEBI:17808 (ChEBI)
IMP MetaboliteCHEBI:17202 (ChEBI)
IMPMetaboliteCHEBI:17202 (ChEBI)
ITP MetaboliteCHEBI:16039 (ChEBI)
ITPA ProteinQ9BY32 (Uniprot-TrEMBL)
ITPA dimerComplexR-HSA-2509833 (Reactome)
ITPMetaboliteCHEBI:16039 (ChEBI)
Ino MetaboliteCHEBI:17596 (ChEBI)
Ino, dIComplexR-ALL-500172 (Reactome)
Iron Sulphur Cluster R-ALL-70986 (Reactome)
L-AlaMetaboliteCHEBI:57972 (ChEBI)
L-selenocysteine residue-GPX1 ProteinP07203 (Uniprot-TrEMBL)
MPT MetaboliteCHEBI:44074 (ChEBI)
Mg2+ MetaboliteCHEBI:18420 (ChEBI)
Mg2+MetaboliteCHEBI:18420 (ChEBI)
Mn2+ MetaboliteCHEBI:29035 (ChEBI)
NADP+MetaboliteCHEBI:18009 (ChEBI)
NADPHMetaboliteCHEBI:16474 (ChEBI)
NDPMetaboliteCHEBI:16862 (ChEBI)
NH4+MetaboliteCHEBI:28938 (ChEBI)
NMPMetaboliteCHEBI:26558 (ChEBI)
NP trimerComplexR-HSA-74237 (Reactome)
NPTDase5:Ca2+,Mg2+ComplexR-HSA-8851367 (Reactome)
NT5C ProteinQ8TCD5 (Uniprot-TrEMBL)
NT5C dimerComplexR-HSA-109468 (Reactome)
NT5C1A ProteinQ9BXI3 (Uniprot-TrEMBL)
NT5C1A tetramerComplexR-HSA-109363 (Reactome)
NT5C1BProteinQ96P26 (Uniprot-TrEMBL)
NT5C2 ProteinP49902 (Uniprot-TrEMBL)
NT5C2 tetramerComplexR-HSA-109318 (Reactome)
NT5C3 holoenzymeComplexR-HSA-109433 (Reactome)
NT5C3-4 ProteinQ9H0P0-4 (Uniprot-TrEMBL)
NT5E ProteinP21589 (Uniprot-TrEMBL)
NT5E:Zn2+ dimerComplexR-HSA-109266 (Reactome)
NT5M ProteinQ9NPB1 (Uniprot-TrEMBL)
NT5M dimerComplexR-HSA-109497 (Reactome)
NTPMetaboliteCHEBI:17326 (ChEBI)
NTPDase1:Ca2+,Mg2+ComplexR-HSA-8850845 (Reactome)
NTPDase2:Ca2+,Mg2+ComplexR-HSA-8851095 (Reactome)
NTPDase3:Ca2+,Mg2+ComplexR-HSA-8851105 (Reactome)
NTPDase4:Ca2+ComplexR-HSA-8851222 (Reactome)
NTPDase6:Ca2+,Mg2+ComplexR-HSA-8851467 (Reactome)
NTPDase7:Ca2+ComplexR-HSA-8851512 (Reactome)
NTPDase8:Ca2+,Mg2+ComplexR-HSA-8851542 (Reactome)
NUDT1 p21 ProteinP36639-3 (Uniprot-TrEMBL)
NUDT1 p26 ProteinP36639-1 (Uniprot-TrEMBL)
NUDT1-2 ProteinP36639-2 (Uniprot-TrEMBL)
NUDT1-4 ProteinP36639-4 (Uniprot-TrEMBL)
NUDT15ProteinQ9NV35 (Uniprot-TrEMBL)
NUDT16 ProteinQ96DE0 (Uniprot-TrEMBL)
NUDT16 dimerComplexR-HSA-2509818 (Reactome)
NUDT18-1ProteinQ6ZVK8-1 (Uniprot-TrEMBL)
NUDT1ComplexR-HSA-2395830 (Reactome) Four NUDT1 ("MTH1") proteins have been identified, generated from a single gene by use of alternative start codons (Oda et al. 1999). The shortest of these, NUDT1 p18, has been biochemically characterized and shown to catalyze hydrolysis of 8-oxo-dGTP (Sakumi et al. 1993). The longer isoforms all consist of the p18 polypeptide with aminoterminal extensions and are presumed to be active as well though they have not been experimentally characterized.
NUDT5 ProteinQ9UKK9 (Uniprot-TrEMBL)
NUDT5 dimerComplexR-HSA-2393948 (Reactome)
NUDT9-1 ProteinQ9BW91-1 (Uniprot-TrEMBL)
NUDT9ComplexR-HSA-2393951 (Reactome)
O2MetaboliteCHEBI:15379 (ChEBI)
OPROPMetaboliteCHEBI:17960 (ChEBI)
PNP ProteinP00491 (Uniprot-TrEMBL)
PPPiMetaboliteCHEBI:18036 (ChEBI)
PPiMetaboliteCHEBI:29888 (ChEBI)
PXLP-AGXT2 ProteinQ9BYV1 (Uniprot-TrEMBL)
PYRMetaboliteCHEBI:32816 (ChEBI)
PiMetaboliteCHEBI:18367 (ChEBI)
R1P MetaboliteCHEBI:35425 (ChEBI)
R1P, dRibPComplexR-ALL-500244 (Reactome)
R5PMetaboliteCHEBI:17797 (ChEBI)
R5PMetaboliteCHEBI:78679 (ChEBI)
SAMHD1 ProteinQ9Y3Z3 (Uniprot-TrEMBL)
SAMHD1:Zn2+ tetramerComplexR-HSA-8866615 (Reactome)
TMP MetaboliteCHEBI:17013 (ChEBI)
TMP, U2MP, U3MP, UMP, dU3MP, dUMPComplexR-ALL-500414 (Reactome)
TMP, UMP, dU5MP, U2MP, U3MPComplexR-ALL-500420 (Reactome)
TYMP ProteinP19971 (Uniprot-TrEMBL)
TYMP dimerComplexR-HSA-74363 (Reactome)
Thy MetaboliteCHEBI:17821 (ChEBI)
Thy, UraComplexR-ALL-500438 (Reactome)
Thy-Rib, (d)UComplexR-ALL-500415 (Reactome)
Thy-Rib, dUComplexR-ALL-500444 (Reactome)
Thy-dRib MetaboliteCHEBI:17748 (ChEBI)
Thy-dRib, Ura-Rib, dUComplexR-ALL-500421 (Reactome)
ThyMetaboliteCHEBI:17821 (ChEBI)
U2MP MetaboliteCHEBI:28070 (ChEBI)
U3MP MetaboliteCHEBI:28895 (ChEBI)
UDP MetaboliteCHEBI:17659 (ChEBI)
UDP,GDP,CDP,dTDPComplexR-ALL-8851224 (Reactome)
UIBAMetaboliteCHEBI:1670 (ChEBI)
UMP MetaboliteCHEBI:16695 (ChEBI)
UMP,GMP,CMP,dTMPComplexR-ALL-8851227 (Reactome)
UPB1 ProteinQ9UBR1 (Uniprot-TrEMBL)
UPB1:Zn2+ComplexR-HSA-73465 (Reactome)
UPP1 ProteinQ16831 (Uniprot-TrEMBL)
UPP1, UPP2ComplexR-HSA-977408 (Reactome)
UPP2 ProteinO95045 (Uniprot-TrEMBL)
UPROPMetaboliteCHEBI:18261 (ChEBI)
UTP MetaboliteCHEBI:15713 (ChEBI)
UTP,GTP,CTP,dTTPComplexR-ALL-8851233 (Reactome)
Ura MetaboliteCHEBI:17568 (ChEBI)
Ura-Rib MetaboliteCHEBI:16704 (ChEBI)
UraMetaboliteCHEBI:17568 (ChEBI)
XANMetaboliteCHEBI:17712 (ChEBI)
XDH ProteinP47989 (Uniprot-TrEMBL)
XDH dimerComplexR-HSA-74244 (Reactome)
XMPMetaboliteCHEBI:15652 (ChEBI)
XTPMetaboliteCHEBI:10049 (ChEBI)
Zn2+ MetaboliteCHEBI:29105 (ChEBI)
b-AlaMetaboliteCHEBI:16958 (ChEBI)
dA MetaboliteCHEBI:17256 (ChEBI)
dAMP MetaboliteCHEBI:17713 (ChEBI)
dC MetaboliteCHEBI:15698 (ChEBI)
dCMP MetaboliteCHEBI:15918 (ChEBI)
dG MetaboliteCHEBI:17172 (ChEBI)
dGMP MetaboliteCHEBI:16192 (ChEBI)
dGMPMetaboliteCHEBI:16192 (ChEBI)
dGTPMetaboliteCHEBI:16497 (ChEBI)
dI MetaboliteCHEBI:28997 (ChEBI)
dIDPMetaboliteCHEBI:28823 (ChEBI)
dIMP MetaboliteCHEBI:28806 (ChEBI)
dIMPMetaboliteCHEBI:28806 (ChEBI)
dITPMetaboliteCHEBI:28807 (ChEBI)
dNTP(4-)MetaboliteCHEBI:61560 (ChEBI)
dRibP MetaboliteCHEBI:28542 (ChEBI)
dRibPMetaboliteCHEBI:28542 (ChEBI)
dTDP MetaboliteCHEBI:18075 (ChEBI)
dTMP MetaboliteCHEBI:17013 (ChEBI)
dTTP MetaboliteCHEBI:18077 (ChEBI)
dU MetaboliteCHEBI:16450 (ChEBI)
dU3MP MetaboliteCHEBI:46322 (ChEBI)
dU5MP MetaboliteCHEBI:17622 (ChEBI)
dUMP MetaboliteCHEBI:17622 (ChEBI)
urateMetaboliteCHEBI:17775 (ChEBI)

Annotated Interactions

View all...
SourceTargetTypeDatabase referenceComment
(d)A, (d)G, (d)IArrowR-HSA-109387 (Reactome)
(d)AMP, (d)GMP, (d)IMPR-HSA-109387 (Reactome)
(d)C, T, (d)UArrowR-HSA-109380 (Reactome)
(d)C, T, (d)UArrowR-HSA-109449 (Reactome)
(d)CMP, TMP, (d)UMPR-HSA-109380 (Reactome)
(d)CMP, TMP, (d)UMPR-HSA-109449 (Reactome)
(d)GMP, (d)IMPR-HSA-109470 (Reactome)
(d)GMP, (d)IMPR-HSA-74248 (Reactome)
(d)UraR-HSA-74376 (Reactome)
2'-deoxynucleosideArrowR-HSA-8866601 (Reactome)
2-hydroxy-AMPArrowR-HSA-2395872 (Reactome)
2-hydroxy-ATPR-HSA-2395872 (Reactome)
2-hydroxy-dAMPArrowR-HSA-2395818 (Reactome)
2-hydroxy-dATPR-HSA-2395818 (Reactome)
2DORPArrowR-HSA-8953339 (Reactome)
2M3OPROAArrowR-HSA-909780 (Reactome)
3AIBArrowR-HSA-73620 (Reactome)
3AIBArrowR-HSA-909755 (Reactome)
3AIBR-HSA-909755 (Reactome)
3AIBR-HSA-909780 (Reactome)
5,6-DihydrothymineArrowR-HSA-73616 (Reactome)
5,6-DihydrothymineR-HSA-73618 (Reactome)
5,6-DihydrouracilArrowR-HSA-73585 (Reactome)
5,6-DihydrouracilR-HSA-73589 (Reactome)
8-hydroxy-dADPR-HSA-2395965 (Reactome)
8-hydroxy-dAMPArrowR-HSA-2395965 (Reactome)
8-oxo-GDPR-HSA-2395873 (Reactome)
8-oxo-GMPArrowR-HSA-2395873 (Reactome)
8-oxo-dGDPR-HSA-2395876 (Reactome)
8-oxo-dGDPR-HSA-2395879 (Reactome)
8-oxo-dGMPArrowR-HSA-2395849 (Reactome)
8-oxo-dGMPArrowR-HSA-2395869 (Reactome)
8-oxo-dGMPArrowR-HSA-2395876 (Reactome)
8-oxo-dGMPArrowR-HSA-2395879 (Reactome)
8-oxo-dGTPR-HSA-2395849 (Reactome)
8-oxo-dGTPR-HSA-2395869 (Reactome)
ADP,GDP,CDP,IDP,UDPArrowR-HSA-8851089 (Reactome)
ADP,GDP,CDP,UDPR-HSA-8851356 (Reactome)
ADP-D-riboseR-HSA-2393939 (Reactome)
ADP-D-riboseR-HSA-5696049 (Reactome)
ADP-RibR-HSA-2393954 (Reactome)
ADPArrowR-HSA-109380 (Reactome)
ADPArrowR-HSA-109387 (Reactome)
ADPArrowR-HSA-109415 (Reactome)
ADPRM:Mn2+mim-catalysisR-HSA-5696049 (Reactome)
AGXT2 tetramermim-catalysisR-HSA-909776 (Reactome)
AGXT2 tetramermim-catalysisR-HSA-909780 (Reactome)
AMP, dAMP, GMP, IMPR-HSA-109278 (Reactome)
AMP,GMP,CMP,UMPArrowR-HSA-8851356 (Reactome)
AMPArrowR-HSA-2393939 (Reactome)
AMPArrowR-HSA-2393954 (Reactome)
AMPArrowR-HSA-5696049 (Reactome)
AMPR-HSA-109415 (Reactome)
ATP,GTP,CTP,ITP,UTPR-HSA-8851089 (Reactome)
Ade-Rib, dA, Gua-Rib, InoArrowR-HSA-109278 (Reactome)
Ade-RibArrowR-HSA-109415 (Reactome)
CDP,GDP,IDP,UDPR-HSA-8851396 (Reactome)
CDP,GDP,UDPArrowR-HSA-8851494 (Reactome)
CMP, TMP, UMPR-HSA-109291 (Reactome)
CMP,GMP,IMP,UMPArrowR-HSA-8851396 (Reactome)
CO2ArrowR-HSA-73591 (Reactome)
CO2ArrowR-HSA-73620 (Reactome)
CTP,GTP,UTPR-HSA-8851494 (Reactome)
Cyt-Rib, Thy-dRib, Ura-RibArrowR-HSA-109291 (Reactome)
DNPH1mim-catalysisR-HSA-8953339 (Reactome)
DPYD dimermim-catalysisR-HSA-73585 (Reactome)
DPYD dimermim-catalysisR-HSA-73616 (Reactome)
DPYS tetramermim-catalysisR-HSA-73589 (Reactome)
DPYS tetramermim-catalysisR-HSA-73618 (Reactome)
G, dGR-HSA-74249 (Reactome)
GDA dimermim-catalysisR-HSA-74255 (Reactome)
GPX1 tetramermim-catalysisR-HSA-71676 (Reactome)
GSHR-HSA-71676 (Reactome)
GSSGArrowR-HSA-71676 (Reactome)
Gu-Rib, dG, Ino, dIArrowR-HSA-109470 (Reactome)
Gu-Rib, dG, Ino, dIArrowR-HSA-74248 (Reactome)
GuaArrowR-HSA-74249 (Reactome)
GuaArrowR-HSA-8953339 (Reactome)
GuaR-HSA-74255 (Reactome)
H+R-HSA-73585 (Reactome)
H+R-HSA-73616 (Reactome)
H2O2ArrowR-HSA-74247 (Reactome)
H2O2ArrowR-HSA-74258 (Reactome)
H2O2R-HSA-71676 (Reactome)
H2OArrowR-HSA-71676 (Reactome)
H2OR-HSA-109278 (Reactome)
H2OR-HSA-109291 (Reactome)
H2OR-HSA-109380 (Reactome)
H2OR-HSA-109387 (Reactome)
H2OR-HSA-109415 (Reactome)
H2OR-HSA-109449 (Reactome)
H2OR-HSA-109470 (Reactome)
H2OR-HSA-109480 (Reactome)
H2OR-HSA-109514 (Reactome)
H2OR-HSA-2393939 (Reactome)
H2OR-HSA-2393954 (Reactome)
H2OR-HSA-2395818 (Reactome)
H2OR-HSA-2395849 (Reactome)
H2OR-HSA-2395869 (Reactome)
H2OR-HSA-2395872 (Reactome)
H2OR-HSA-2395873 (Reactome)
H2OR-HSA-2395876 (Reactome)
H2OR-HSA-2395879 (Reactome)
H2OR-HSA-2395965 (Reactome)
H2OR-HSA-2509793 (Reactome)
H2OR-HSA-2509816 (Reactome)
H2OR-HSA-2509827 (Reactome)
H2OR-HSA-2509831 (Reactome)
H2OR-HSA-2509838 (Reactome)
H2OR-HSA-5696049 (Reactome)
H2OR-HSA-73589 (Reactome)
H2OR-HSA-73591 (Reactome)
H2OR-HSA-73618 (Reactome)
H2OR-HSA-73620 (Reactome)
H2OR-HSA-74247 (Reactome)
H2OR-HSA-74248 (Reactome)
H2OR-HSA-74255 (Reactome)
H2OR-HSA-74258 (Reactome)
H2OR-HSA-8850846 (Reactome)
H2OR-HSA-8850854 (Reactome)
H2OR-HSA-8851089 (Reactome)
H2OR-HSA-8851110 (Reactome)
H2OR-HSA-8851129 (Reactome)
H2OR-HSA-8851225 (Reactome)
H2OR-HSA-8851234 (Reactome)
H2OR-HSA-8851356 (Reactome)
H2OR-HSA-8851396 (Reactome)
H2OR-HSA-8851494 (Reactome)
H2OR-HSA-8851538 (Reactome)
H2OR-HSA-8851550 (Reactome)
H2OR-HSA-8866601 (Reactome)
H2OR-HSA-8953339 (Reactome)
HypArrowR-HSA-74242 (Reactome)
HypR-HSA-74247 (Reactome)
IDPR-HSA-2509816 (Reactome)
IMPArrowR-HSA-2509816 (Reactome)
IMPArrowR-HSA-2509827 (Reactome)
ITPA dimermim-catalysisR-HSA-2509827 (Reactome)
ITPA dimermim-catalysisR-HSA-2509831 (Reactome)
ITPA dimermim-catalysisR-HSA-2509838 (Reactome)
ITPR-HSA-2509827 (Reactome)
Ino, dIR-HSA-74242 (Reactome)
L-AlaArrowR-HSA-909776 (Reactome)
L-AlaArrowR-HSA-909780 (Reactome)
Mg2+ArrowR-HSA-2509793 (Reactome)
Mg2+ArrowR-HSA-2509816 (Reactome)
Mg2+ArrowR-HSA-2509827 (Reactome)
Mg2+ArrowR-HSA-2509831 (Reactome)
Mg2+ArrowR-HSA-2509838 (Reactome)
NADP+ArrowR-HSA-73585 (Reactome)
NADP+ArrowR-HSA-73616 (Reactome)
NADPHR-HSA-73585 (Reactome)
NADPHR-HSA-73616 (Reactome)
NDPArrowR-HSA-8850846 (Reactome)
NDPArrowR-HSA-8851110 (Reactome)
NDPArrowR-HSA-8851538 (Reactome)
NDPR-HSA-8850854 (Reactome)
NDPR-HSA-8851129 (Reactome)
NDPR-HSA-8851550 (Reactome)
NH4+ArrowR-HSA-73591 (Reactome)
NH4+ArrowR-HSA-73620 (Reactome)
NH4+ArrowR-HSA-74255 (Reactome)
NMPArrowR-HSA-8850854 (Reactome)
NMPArrowR-HSA-8851129 (Reactome)
NMPArrowR-HSA-8851550 (Reactome)
NP trimermim-catalysisR-HSA-74242 (Reactome)
NP trimermim-catalysisR-HSA-74249 (Reactome)
NPTDase5:Ca2+,Mg2+mim-catalysisR-HSA-8851356 (Reactome)
NT5C dimermim-catalysisR-HSA-109470 (Reactome)
NT5C dimermim-catalysisR-HSA-109480 (Reactome)
NT5C1A tetramermim-catalysisR-HSA-109380 (Reactome)
NT5C1A tetramermim-catalysisR-HSA-109387 (Reactome)
NT5C1Bmim-catalysisR-HSA-109415 (Reactome)
NT5C2 tetramermim-catalysisR-HSA-74248 (Reactome)
NT5C3 holoenzymemim-catalysisR-HSA-109449 (Reactome)
NT5E:Zn2+ dimermim-catalysisR-HSA-109278 (Reactome)
NT5E:Zn2+ dimermim-catalysisR-HSA-109291 (Reactome)
NT5M dimermim-catalysisR-HSA-109514 (Reactome)
NTPDase1:Ca2+,Mg2+mim-catalysisR-HSA-8850846 (Reactome)
NTPDase1:Ca2+,Mg2+mim-catalysisR-HSA-8850854 (Reactome)
NTPDase2:Ca2+,Mg2+mim-catalysisR-HSA-8851089 (Reactome)
NTPDase3:Ca2+,Mg2+mim-catalysisR-HSA-8851110 (Reactome)
NTPDase3:Ca2+,Mg2+mim-catalysisR-HSA-8851129 (Reactome)
NTPDase4:Ca2+mim-catalysisR-HSA-8851225 (Reactome)
NTPDase4:Ca2+mim-catalysisR-HSA-8851234 (Reactome)
NTPDase6:Ca2+,Mg2+mim-catalysisR-HSA-8851396 (Reactome)
NTPDase7:Ca2+mim-catalysisR-HSA-8851494 (Reactome)
NTPDase8:Ca2+,Mg2+mim-catalysisR-HSA-8851538 (Reactome)
NTPDase8:Ca2+,Mg2+mim-catalysisR-HSA-8851550 (Reactome)
NTPR-HSA-8850846 (Reactome)
NTPR-HSA-8851110 (Reactome)
NTPR-HSA-8851538 (Reactome)
NUDT15mim-catalysisR-HSA-2395869 (Reactome)
NUDT15mim-catalysisR-HSA-2395876 (Reactome)
NUDT16 dimermim-catalysisR-HSA-2509793 (Reactome)
NUDT16 dimermim-catalysisR-HSA-2509816 (Reactome)
NUDT18-1mim-catalysisR-HSA-2395873 (Reactome)
NUDT18-1mim-catalysisR-HSA-2395879 (Reactome)
NUDT18-1mim-catalysisR-HSA-2395965 (Reactome)
NUDT1mim-catalysisR-HSA-2395818 (Reactome)
NUDT1mim-catalysisR-HSA-2395849 (Reactome)
NUDT1mim-catalysisR-HSA-2395872 (Reactome)
NUDT5 dimermim-catalysisR-HSA-2393939 (Reactome)
NUDT9mim-catalysisR-HSA-2393954 (Reactome)
O2R-HSA-74247 (Reactome)
O2R-HSA-74258 (Reactome)
OPROPArrowR-HSA-909776 (Reactome)
PPPiArrowR-HSA-8866601 (Reactome)
PPiArrowR-HSA-2395818 (Reactome)
PPiArrowR-HSA-2395849 (Reactome)
PPiArrowR-HSA-2395869 (Reactome)
PPiArrowR-HSA-2395872 (Reactome)
PPiArrowR-HSA-2509827 (Reactome)
PPiArrowR-HSA-2509831 (Reactome)
PPiArrowR-HSA-2509838 (Reactome)
PYRR-HSA-909776 (Reactome)
PYRR-HSA-909780 (Reactome)
PiArrowR-HSA-109278 (Reactome)
PiArrowR-HSA-109291 (Reactome)
PiArrowR-HSA-109380 (Reactome)
PiArrowR-HSA-109387 (Reactome)
PiArrowR-HSA-109415 (Reactome)
PiArrowR-HSA-109449 (Reactome)
PiArrowR-HSA-109470 (Reactome)
PiArrowR-HSA-109480 (Reactome)
PiArrowR-HSA-109514 (Reactome)
PiArrowR-HSA-2395873 (Reactome)
PiArrowR-HSA-2395876 (Reactome)
PiArrowR-HSA-2395879 (Reactome)
PiArrowR-HSA-2395965 (Reactome)
PiArrowR-HSA-2509793 (Reactome)
PiArrowR-HSA-2509816 (Reactome)
PiArrowR-HSA-74248 (Reactome)
PiArrowR-HSA-8850846 (Reactome)
PiArrowR-HSA-8850854 (Reactome)
PiArrowR-HSA-8851089 (Reactome)
PiArrowR-HSA-8851110 (Reactome)
PiArrowR-HSA-8851129 (Reactome)
PiArrowR-HSA-8851225 (Reactome)
PiArrowR-HSA-8851234 (Reactome)
PiArrowR-HSA-8851356 (Reactome)
PiArrowR-HSA-8851396 (Reactome)
PiArrowR-HSA-8851494 (Reactome)
PiArrowR-HSA-8851538 (Reactome)
PiArrowR-HSA-8851550 (Reactome)
PiR-HSA-112265 (Reactome)
PiR-HSA-74242 (Reactome)
PiR-HSA-74249 (Reactome)
PiR-HSA-74376 (Reactome)
R-HSA-109278 (Reactome) 5'-nucleotidase (NT5E) associated with the plasma membrane catalyzes the reactions of extracellular AMP, dAMP, GMP, or IMP with H2O to yield the corresponding nucleoside and orthophosphate. The active enzyme is a glycolipid-anchored dimer (Misumi et al. 1990; Thompson et al. 1987; Zimmerman 1992)
R-HSA-109291 (Reactome) 5'-nucleotidase (NT5E) associated with the plasma membrane catalyzes the reactions of extracellular CMP, TMP, or UMP with H2O to yield the corresponding nucleoside and orthophosphate. The active enzyme is a glycolipid-anchored dimer (Misumi et al. 1990; Thompson et al. 1987; Zimmerman 1992)
R-HSA-109380 (Reactome) Cytosolic 5'-nucleotidase IA (NT5C1A) catalyzes the hydrolysis of (deoxy)cytidine monophosphate, thymidine monophosphate and (deoxy)uridine monophosphate to the corresponding nucleosides plus orthophosphate. The enzyme is allosterically activated by ADP (Hunsucker et al. 2001). The human enzyme is inferred to be a homotetramer with one Mg++ ion bound per subunit based on its similarity to the pigeon heart enzyme (Bianchi and Spychala 2003; Sala-Newby et al. 1999; Skladanowski and Newby 1990).
R-HSA-109387 (Reactome) Cytosolic 5'-nucleotidase IA catalyzes the hydrolysis of purine ribo- and deoxyribonucleoside monophosphates to nucleosides plus orthophosphate. The enzyme is allosterically activated by ADP (Hunsucker et al. 2001). The human enzyme is inferred to be a homotetramer with one Mg++ ion bound per subunit, based on its similarity to the pigeon heart enzyme (Bianchi and Spychala 2003; Sala-Newby et al. 1999; Skladanowski and Newby 1990).
R-HSA-109415 (Reactome) 5'-nucleotidase cytosolic IB catalyzes the hydrolysis of AMP to yield adenosine and orthophosphate. The human enzyme has been identified as the product of a recombinant DNA clone, but its biochemical properties are largely inferred from those of the better studied mouse and rat enzymes (Sala-Newby and Newby 2001; Sala-Newby et al. 2003).
R-HSA-109449 (Reactome) Cytosolic 5'-nucleotidase 3 (NT5C3) catalyzes the hydrolysis of pyrimidine nucleoside monophosphates (d)CMP, TMP, and (d)UMP to nucleosides plus orthophosphate. While the enzyme appears to be present in many tissues, it is especially abundant in erythrocytes, where it may function to remove excess pyrimidine nucleotides generated by nucleic acid breakdown, while sparing purine nucleotides needed for red cell energy metabolism. Deficiencies in the enzyme are associated with a form of hemolytic anemia and its inactivation by heavy metals may be responsible for some hematological abnormalities associated with lead poisoning (Marinaki et al. 2001; Rees et al. 2003). The active form of the enzyme is a monomer. It has an absolute requirement for Mg++, and is inactive against purine nucleotides (Amici et al. 1997; Amici and Magni 2002).
R-HSA-109470 (Reactome) Cytosolic 5'3'-nucleotidase (NT5C) catalyzes the hydrolysis of deoxy- and ribo- guanosine and inosine nucleoside monophosphates to yield the corresponding nucleosides and orthophosphate. The active form of the enzyme is a homodimer, with an absolute requirement for Mg++ (Hoglund and Reichard 1990; Rampazzo et al. 2000). This enzyme appears to play a central role in the "substrate cycles" that regulate cytosolic deoxynucleotide levels (Gazziola et al. 2001).
R-HSA-109480 (Reactome) Cytosolic 5'3'-nucleotidase (NT5C) catalyzes the hydrolysis of uridine 2', 3', and 5' monophosphates, dexoyuridine 3' and 5' monophosphates, and thymidine monophosphate to yield the corresponding (deoxy)nucleosides and orthophosphate. The active form of the enzyme is a homodimer, with an absolute requirement for Mg++ (Hoglund and Reichard 1990; Rampazzo et al. 2000). This enzyme appears to play a central role in the "substrate cycles" that regulate cytosolic deoxynucleotide levels (Gazziola et al. 2001).
R-HSA-109514 (Reactome) 5'3'-Nucleotidase, mitochondrial (NT5M) is the major nucleotidase of human mitochondria, catalyzing the hydrolysis of TMP, uridine 2'-, 3'-, and 5'-monophosphates, and dUMP to yield the corresponding (deoxy)nucleosides and orthophosphate. It may play a central role in "substrate cycles" to regulate mitochondrial deoxynucleotide levels, especially in non-dividing cells (Rampazzo et al. 2000; Gallinaro et al. 2002). The active form of the enzyme is a homodimer, with an absolute requirement for Mg++ (Rampazzo et al. 2000; Rinaldo-Matthis et al. 2002).
R-HSA-112265 (Reactome) Cytosolic thymidine phosphorylase (TYMP) catalyzes the reversible reactions of thymidine or deoxyuridine with orthophosphate to form thymine or uracil and 2-deoxy-D-ribose 1-phosphate. The active form of the enzyme is a homodimer (Desgranges et al. 1981; Norman et al. 2004; Usuki et al. 1992).
R-HSA-2393939 (Reactome) Cytosolic NUDT5 dimer (ADP-ribose pyrophosphatase) catalyzes the hydrolysis of ADP-ribose to form AMP and D-ribose 5-phosphate. Each NUDT5 subunit is associated with three magnesium ions (Zha et al. 2006, 2008). NUDT5 also catalyzes the hydrolysis of 8-oxo-dGTP but with a strongly alkaline pH optimum (Ito et al. 2011) so the physiological relevance of this reaction is unclear and it is not annotated here.
R-HSA-2393954 (Reactome) Mitochondrial NUDT9 (ADP-ribose pyrophosphatase) catalyzes the hydrolysis of ADP-ribose to form AMP and D-ribose 5-phosphate. The active enzyme is the longer of two isoforms generated by alternative splicing and is a monomer complexed with two magnesium ions (Perraud et al. 2003; Shen et al. 2003).
R-HSA-2395818 (Reactome) NUDT1 (MTH1) catalyzes the reaction of 2-hydroxy-dATP and water to form 2-hydroxy-dAMP and PPi (pyrophosphate). Four NUDT1 proteins have been identified, encoded by a single gene with alternative start codons (Oda et al. 1999). The shortest of these, NUDT1 p18, has been shown to catalyze hydrolysis of 2-hydroxy-dATP (Fujikawa et al. 1993; Sakai et al. 2002). The active enzyme is a monomer associated with a magnesium ion (Mishima et al. 2004). The longer isoforms all consist of the p18 polypeptide with aminoterminal extensions and are presumed to be active as well but have not been experimentally characterized. The p18 isoform is predominantly cytosolic (Kang et al. 1995). Its expression prevents the accumulation of modified adenosine bases in DNA in mutant mouse cells lacking endogenous NUDT1 activity (Yoshimura et al. 2003).

Together, these data support the hypothesis that by cleaving 2-hydroxy-dATP and thus preventing its incorporation into DNA, NUDT1 provides a physiologically important defense against mutagenesis due to oxidative stress. This hypothesis is further supported by the demonstration that mice lacking NUDT1 show an increased lifetime incidence of liver and other tumors compared to normal controls, and that rapidly metabolizing tumor cells in culture are killed under conditions where synthesis of NUDT1 protein is suppressed or its catalytic activity is inhibited (Gad et al. 2014; Huber et al. 2014).

R-HSA-2395849 (Reactome) NUDT1 (MTH1) catalyzes the reaction of 8-oxo-dGTP and water to form 8-oxo-dGMP and PPi (pyrophosphate). Four NUDT1 proteins have been identified, encoded by a single gene with alternative start codons (Oda et al. 1999). The shortest of these, NUDT1 p18, has been biochemically (Sakumi et al. 1993; Takagi et al. 2012) and structurally (Mishima et al. 2004) characterized and shown to catalyze hydrolysis of 8-oxo-dGTP. The active enzyme is a monomer associated with a magnesium ion (Mishima et al. 2004). The longer isoforms all consist of the p18 polypeptide with aminoterminal extensions and are presumed to be active as well but have not been experimentally characterized. The p18 isoform is predominantly cytosolic (Kang et al. 1995). Its expression prevents the accumulation of oxo-guanine bases in DNA in mutant mouse cells lacking endogenous NUDT1 activity (Yoshimura et al. 2003).

Together, these data support the hypothesis that by cleaving 8-oxo-dGTP and thus preventing its incorporation into DNA NUDT1 provides a physiologically important defense against mutagenesis due to oxidative stress. This hypothesis is further supported by the demonstration that mice lacking NUDT1 show an increased lifetime incidence of liver and other tumors compared to normal controls, and that rapidly metabolizing tumor cells in culture are killed under conditions where synthesis of NUDT1 protein is suppressed or its catalytic activity is inhibited (Gad et al. 2014; Huber et al. 2014).

R-HSA-2395869 (Reactome) NUDT15 (MTH2) catalyzes the reaction of 8-oxo-dGTP and water to form 8-oxo-dGMP and PPi (pyrophosphate). Cai et al. (2003) first identified this activity in studies of the homologous mouse protein; the activity of the human NUDT15 protein has since been confirmed experimentally (Takagi et al. 2012).
R-HSA-2395872 (Reactome) NUDT1 (MTH1) catalyzes the reaction of 2-hydroxy-ATP and water to form 2-hydroxy-AMP and PPi (pyrophosphate). Four NUDT1 proteins have been identified, encoded by a single gene with alternative start codons (Oda et al. 1999). The shortest of these, NUDT1 p18, has been shown to catalyze hydrolysis of 2-hydroxy-dATP (Fujikawa et al. 2001). The active enzyme is a monomer associated with a magnesium ion (Mishima et al. 2004). The longer isoforms all consist of the p18 polypeptide with aminoterminal extensions and are presumed to be active as well, but have not been experimentally characterized. The p18 isoform is predominantly cytosolic (Kang et al. 1995).
R-HSA-2395873 (Reactome) NUDT18 (MTH3) catalyzes the reaction of 8-oxo-GDP and water to form 8-oxo-GMP and Pi (orthophosphate) (Takagi et al. 2012). The subcellular location of NUDT18 has not been established but is assumed to be cytosolic like NUDT1.
R-HSA-2395876 (Reactome) NUDT15 (MTH2) catalyzes the reaction of 8-oxo-dGDP and water to form 8-oxo-dGMP and Pi (orthophosphate) (Takagi et al. 2012). The subcellular location of NUDT15 has not been established but is assumed to be cytosolic like NUDT1.
R-HSA-2395879 (Reactome) NUDT18 (MTH3) catalyzes the reaction of 8-oxo-dGDP and water to form 8-oxo-dGMP and Pi (orthophosphate) (Takagi et al. 2012). The subcellular location of NUDT18 has not been established but is assumed to be cytosolic like NUDT1.
R-HSA-2395965 (Reactome) NUDT18 (MTH3) catalyzes the reaction of 8-hydroxy-dADP and water to form 8-hydroxy-dAMP and Pi (orthophosphate) (Takagi et al. 2012). The subcellular location of NUDT18 has not been established but is assumed to be cytosolic like NUDT1.
R-HSA-2509793 (Reactome) NUDT16 dimer catalyzes the reaction of dIDP and water to form dIMP and Pi (orthophosphate). Mg++ is required for enzymatic activity. The protein is mostly located in the nucleus and concentrated in the nucleolus, where it can also mediate the decapping of U8 small nucleolar RNA (Iyama et al. 2010; Peculis et al. 2007).
R-HSA-2509816 (Reactome) NUDT16 dimer catalyzes the reaction of IDP and water to form IMP and Pi (orthophosphate). Mg++ is required for enzymatic activity. The protein is mostly located in the nucleus and concentrated in the nucleolus, where it can also mediate the decapping of U8 small nucleolar RNA (Iyama et al. 2010; Peculis et al. 2007).
R-HSA-2509827 (Reactome) Cytosolic ITPA dimer catalyzes the reaction of ITP and water to form IMP and PPi (pyrophosphate). Mg++ is required for enzymatic activity. The hydrolysis of ITP is thought to prevent its incorporation into mRNA, which would lead to aberrant protein synthesis (Lin et al. 2001; Abolhassani et al. 2010).
R-HSA-2509831 (Reactome) Cytosolic ITPA dimer catalyzes the reaction of XTP and water to form XMP and PPi (pyrophosphate). Mg++ is required for enzymatic activity. The hydrolysis of XTP is thought to prevent its incorporation into mRNA, which would lead to aberrant protein synthesis (Lin et al. 2001; Abolhassani et al. 2010).
R-HSA-2509838 (Reactome) Cytosolic ITPA dimer catalyzes the reaction of dITP and water to form dIMP and PPi (pyrophosphate). Mg++ is required for enzymatic activity. The hydrolysis of dITP is thought to prevent its incorporation into DNA, which would be mutagenic (Lin et al. 2001; Abolhassani et al. 2010).
R-HSA-5696049 (Reactome) Manganese-dependent ADP-ribose/CDP-alcohol diphosphatase (ADPRM:Mn2+) can mediate the hydrolysis of ADP-ribose and less efficiently, CDP-alcohols and 2',3'-cAMP (Cabezas et al. 2015).
R-HSA-71676 (Reactome) Cytosolic glutathione peroxidase (GPX1) tetramer catalyzes the reaction of reduced glutathione and hydrogen peroxide to form reduced glutathione and water (Chu et al. 1993).
R-HSA-73585 (Reactome) Cytosolic dihydropyrimidine dehydrogenase catalyzes the reaction of uracil and NADPH + H+ to form 5,6-dihydrouracil and NADP+. The mechanism of the human reaction is inferred from that of the well-characterized pig enzyme (Yokota et al. 1994).
R-HSA-73589 (Reactome) Cytosolic dihydropyrimidinase tetramer catalyzes the reaction of 5,6-dihydrouracil and water to form 3-ureidopropionate (Hamajima et al. 1998).
R-HSA-73591 (Reactome) Cytosolic 3-ureidopropionase catalyzes the reaction of 3-ureidopropionate and water to form beta-alanine, CO2, and NH3 (van Kuilenberg et al. 2004).
R-HSA-73616 (Reactome) Cytosolic dihydropyrimidine dehydrogenase catalyzes the reaction of thymine and NADPH + H+ to form 5,6-dihydrothymine and NADP+. The mechanism of the human reaction is inferred from that of the well-characterized pig enzyme (Yokota et al. 1994).
R-HSA-73618 (Reactome) Cytosolic dihydropyrimidinase tetramer catalyzes the reaction of 5,6-dihydrothymine and water to yield 3-ureidoisobutyrate (Hamajima et al. 1998).
R-HSA-73620 (Reactome) Cytosolic UPB1 (beta-ureidopropionase) catalyzes the reaction of 3-ureidoisobutyrate and H2O to form (R)-3-aminoisobutyrate, CO2, and NH3 (Tamaki et al. 2000; van Kuilenburg et al. 2004).
R-HSA-74242 (Reactome) Cytosolic nucleoside phosphorylase (NP) trimer catalyzes the reversible reaction of inosine or deoxyinosine with orthophosphate to form hypoxanthine and ribose 1-phosphate or deoxyribose 1-phosphate (Ealick et al. 1990; Wiginton et al. 1980). While NP is active with either nuckeotide in vitro, levels of deoxyinosine are normally low in vivo, limiting the extent of this reaction. NP deficiency in vivo is associated with defects in purine nucleotide salvage and leads to immunodeficiency (Williams et al. 1987).
R-HSA-74247 (Reactome) Cytosolic xanthine dehydrogenase (XDH) catalyzes the reaction of hypoxanthine with H2O and oxygen to form xanthine and H2O2. The active form of the enzyme is a dimer (Saksela and Raivio 1996; Yamaguchi et al. 2007).
R-HSA-74248 (Reactome) Cytosolic purine 5'-nucleotidase (NT5C2) catalyzes the hydrolysis of GMP, dGMP, IMP, and dIMP to yield the corresponding nucleosides and orthophosphate (Bianchi and Spychala 2003; Spychala et al. 1988). The active form of the enzyme is a tetramer and has an absolute requirement for magnesium ions (Spychala et al. 1988; Wallden et al. 2007). Consistent with the biochemical properties of purified enzyme, cultured cells overexpressing the enzyme from a recombinant DNA clone showed enhanced activity against inosine and guanosine monophosphates, but not adenosine monophosphate (Gazziola et al. 2001; Sala-Newby et al. 2000).
R-HSA-74249 (Reactome) Cytosolic nucleoside phosphorylase (NP) trimer catalyzes the reversible reaction of guanosine or deoxyguanosine with orthophosphate to form guanine and ribose 1-phosphate or deoxyribose 1-phosphate (Ealick et al. 1990; Wiginton et al. 1980). While NP is active with either nuckeotide in vitro, levels of deoxyguanosine are normally low in vivo, limiting the extent of this reaction. NP deficiency in vivo is associated with defects in purine nucleotide salvage and leads to immunodeficiency (Williams et al. 1987).
R-HSA-74255 (Reactome) Cytosolic guanine deaminase (GDA) catalyzes the reaction of guanine and water to form xanthine and ammonia (Yuan et al. 1999). The active enzyme is a homodimer (Murphy et al. 2009).
R-HSA-74258 (Reactome) Cytosolic xanthine dehydrogenase (XDH) catalyzes the reaction of xanthine with H2O to form urate and H2O2. The active form of the enzyme is a dimer (Saksela and Raivio 1996; Yamaguchi et al. 2007).
R-HSA-74376 (Reactome) Cytosolic uridine phosphorylase (isoforms UPP1 and UPP2) catalyzes the reversible reactions of uridine or deoxyuridine with orthophosphate to yield uracil and ribose 1-phosphate or deoxyribose 1-phosphate (Watanabe and Uchida 1995; Johansson, 2003). The active form of UPP1 is a dimer (Rooslid et al. 2009).
R-HSA-8850846 (Reactome) NTPDase1 (CD39) is a plasma membrane-bound ectonucleotidase encoded by the ENTPD1 gene that hydrolyzes extracellular NTPs to NMPs, via corresponding NDP intermediates (Lemmens et al. 2000, Kukulski et al. 2005). NTPDase1 is expressed on endothelial cells, smooth muscle cells and most leukocytes. The vascular endothelial NTPDase1 regulates platelet aggregation and thrombosis (Kaczmarek et al. 1996, Enjoyji et al. 1999). In mice, NTPDase1 is expressed at the surface of epidermal dendritic cells (Langerhans cells) and is involved in regulation of immune response to skin irritants (Mizumoto et al. 2002). NTPDase1 expressed in vascular smooth muscle cells regulates vasomotion (Kauffenstein et al. 2010, reviewed by Kukulski et al. 2011). In regulatory T lymphocytes (Tregs) and other leukocytes NTPDase1 regulates inflammatory processes (Deaglio et al. 2007).
R-HSA-8850854 (Reactome) NTPDase1 (CD39), a plasma membrane-bound nucleotide phosphatase encoded by the ENTPD1 gene, hydrolyzes extracellular NDPs to corresponding NMPs (Lemmens et al. 2000, Kukulski et al. 2005) which contributes to inhibition of platelet aggregation and thrombosis (Kaczmarek et al. 1996, Enjyoji et al. 1999, Marcus et al. 2003).
R-HSA-8851089 (Reactome) NTPDase2 (CD39L1), encoded by the ENTPD2 gene, is an ectonucleoside triphosphate diphosphohydrolase that is expressed at the plasma membrane where it hydrolyzes extracellular nucleoside triphosphates (ATP, GTP, CTP, ITP, UTP) to the respective nucleoside diphosphate (ADP, GDP, CDP, IDP, UDP) in the presence of Ca2+ of Mg2+ ions. NTPDase2 is only marginally active in hydrolyzing nucleoside diphosphates, such as ADP and UDP (Kegel et al. 1997, Kirley et al. 1997, Mateo et al. 1999). The alpha splicing isoform of NTPDase2 is expressed at the plasma membrane, while beta and gamma isoforms are expressed in the endoplasmic reticulum (Mateo et al. 2003). NTPDase2 may oligomerize and the oligomerization state may affect substrate specificity (Failer et al. 2003).

NTPDase2 may contribute to vascular hemostasis by exerting an opposing role to NTPDase1 (Sévigny et al. 2002).

R-HSA-8851110 (Reactome) NTPDase3 (CD39L3), encoded by the ENTPD3 gene, is a plasma membrane-bound ectonucleotidase that hydrolyzes extracellular NTPs to NMPs via corresponding NDP intermediates (Smith and Kirley 1998, Lavoie et al. 2004, Kukulski et al. 2005). NTPDase3 is about 3 times more efficient in hydrolyzing ATP than ADP (Smith and Kirley 1998). NTPDase3 is expressed in some neurons (Belcher et al. 2006, Lavoie et al. 2010) where it may be involved in sleep-wake behaviour (Belcher et al. 2006). NTPDase3 is also expressed in islet cells where it may regulate insulin secretion (Lavoie et al. 2010).
R-HSA-8851129 (Reactome) NTPDase3 (CD39L3), encoded by the ENTPD3 gene, is a plasma membrane-bound ectonucleotidase that hydrolyzes extracellular NDPs to corresponding NMPs (Smith and Kirley 1998, Lavoie et al. 2004, Vorhoff et al. 2005, Kukulski et al. 2005).
R-HSA-8851225 (Reactome) NTPDase4 (UDPase), encoded by the ENTPD4 gene, belongs to the E-NTPDase family of nucleotide phosphatases. NTPDase4 localizes to the Golgi membrane, with active site on the Golgi lumen side. In the presence of Ca2+, NTPDase4 hydrolyzes nucleoside diphosphates UDP, GDP, CDP and dTDP to nucleoside monophosphates UMP, GMP, CMP and dTMP, respectively (Wang and Guidotti 1998).
R-HSA-8851234 (Reactome) NTPDase4 (UDPase), encoded by the ENTPD4 gene, is an E-NTPDase family member that localizes to the Golgi membrane and can hydrolyze nucleoside triphosphates UTP, GTP, CTP and TTP to nucleoside diphosphates UDP, GDP, CDP and TDP, respectively, in the Golgi lumen. NTPDase4 hydrolyzes nucleoside triphosphates less efficiently than nucleoside diphosphates. Ca2+ is needed for NTPDase4 activity (Wang and Guidotti 1998).
R-HSA-8851356 (Reactome) NTPDase5 (CD39L4), encoded by the ENTPD5 gene, is an E-NTPDase family member that is secreted to the extracellular space where it hydrolyzes nucleoside diphosphates UDP, GDP, CDP and ADP (listed in the order of preference) to nucleoside monophosphates UMP, GMP, CMP and AMP, respectively. In vitro, NTPDase5 can hydrolyze nucleoside triphosphates GTP, CTP, UTP and ATP to corresponding nucleoside diphosphates but with very low efficiency. NTPDase5 requires Ca2+ or Mg2+ for catalytic activity (Mulero et al. 1999). NTPDase5 is most catalytically active as a monomer, although it can also form disulfide-linked dimers (Mulero et al. 2000).

NTPDase5 may function in the endoplasmic reticulum (ER), where its UDPase activity could contribute to protein glycosylation and folding. NTPDase5 may alleviate ER stress induced by protein overload caused by oncogenic PI3K/AKT signaling in cancer cells. NTPDase5 is over-expressed in tumors with activated AKT and is known as the PCPH oncogene. The underlying mechanism of NTPDase5 over-expression may be AKT-mediated inhibition of FOXO proteins, which are probable transcriptional repressors of the ENTPD5 gene (Fang et al. 2010, Shen et al. 2011).

R-HSA-8851396 (Reactome) NTPDase6 (CD39L2), encoded by the ENTPD6 gene, is an ectonucleotide phosphatase of the E-NTPDase family that can be secreted (Yeung et al. 2000). Secretion involves the removal of the first 77 amino acids at the N-terminus by an unknown peptidase. Secreted NTPDase6 hydrolyzes nucleoside diphosphates GDP, IDP and, less efficiently, UDP and CDP to nucleoside monophosphates GMP, IMP, UMP and CMP, respectively. Secreted NTPDase6 hydrolyzes ADP to AMP and nucleoside triphosphates GTP, ITP, UTP and CTP to corresponding nucleoside diphosphates with very low efficacy (Hicks-Berger et al. 2000, Yeung et al. 2000, Ivanenkov et al. 2003). NTPDase6 requires Ca2+ or Mg2+ for catalytic activity (Hicks-Berger et al. 2000, Ivanenkov et al. 2003).

NTPDase6 may also be able to function as a membrane-bound enzyme, but its catalytic rate is very low and accounts for up to 10% of NTPDase6 activity (Hicks-Berger et al. 2000).

R-HSA-8851494 (Reactome) NTPDase7 (LALP1), encoded by the ENTPD7 gene, is a cytoplasmic vesicle membrane-bound nucleotide phosphatase that hydrolyzes nucleoside triphosphates CTP, GTP and UTP to nucleoside diphosphates CDP, GDP and UDP, respectively. NTPDase7 may have a low activity towards ATP and nucleoside diphosphates (Shi et al. 2001). NTPDase7 requires Ca2+ for catalytic activity (Shi et al. 2001). In mice, NTPDase7 was shown to regulate development of IL17-secreting Th17 cells in the small intestine, possibly by regulating extracellular ATP levels (Kusu et al. 2013).
R-HSA-8851538 (Reactome) NTPDase8, encoded by the ENTPD8 gene, is an E-NTPDase family ectonucleotide phosphatase that, in the presence of Ca2+ or Mg2+, hydrolyzes NTPs to NMPs, via corresponding NDP intermediates. NTPDase8 is more efficient in hydrolyzing NTPs than NDPs. NTPDase8 provides the main ectonucleotide phosphatase activity in rat and porcine livers (Sevigny et al. 2000, Fausther et al. 2007).
R-HSA-8851550 (Reactome) NTPDase8, encoded by the ENTPD8 gene, is the main liver ectonucleotide phosphatase. NTPDase8 belongs to the E-NTPDase family of nucleotide phosphatases and can hydrolyze NDPs to corresponding NMPs (Sévigny et al. 2000, Bigonnesse et al. 2004, Fausther et al. 2007).
R-HSA-8866601 (Reactome) SAMHD1:Zn2+ tetramer (Deoxynucleoside triphosphate triphosphohydrolase SAMHD1, also known as SAM domain and HD domain-containing protein 1) catalyzes the hydrolysis of dNTPs (2'-deoxynucleoside 5'-triphosphates) to form 2'-deoxynucleosides and PPPi (triphosphate) (Goldstone et al. 2011; Powell et al. 2011). The active form of the enzyme is a tetramer with one Zn2+ ion associated with each monomer subunit (Yan et al. 2013; Zhu et al. 2013) localized in the nucleus (Franzolin et al. 2013; Rice et al. 2009). The enzyme is activated by dGTP (Powell et al. 2011).

SAMHD1 activity may play a role in regulating the size of the nuclear pools of dNTPs and dissipating these pools at the end of the S phase of the cell cycle (Franzolin et al. 2013) and it may play a role as well in regulating cellular antiviral responses (Goldstone et al. 2011; Rice et al. 2009).

R-HSA-8953339 (Reactome) 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 (DNPH1 aka c-Myc-responsive protein RCL) is a cytosolic protein which catalyses the cleavage of the N-glycosidic bond of deoxyribonucleoside 5'-monophosphates to yield deoxyribose 5-phosphate (2DORP) and a purine or pyrimidine base. Of the six 2'-deoxynucleoside 5'-monophosphates, DNPH1 has highest affinity for the purine deoxynucleotide dGMP (Amiable et al. 2013). The same affinity for purine deoxynucleotides over pyrimidine deoxynucleotides was observed for rat Dnph1 (Ghiorghi et al. 2007). DNPH1 is a potential target for anti-cancer therapies (Amiable et al. 2014) as it is involved in cellular proliferation and is up-regulated in several types of cancer.
R-HSA-909755 (Reactome) The mitochondrial uptake of cytosolic (R)-3-aminoisobutyric acid in human cells is inferred from the corresponding process known to occur in rat (Tamaki et al. 2000).
R-HSA-909765 (Reactome) The mitochondrial uptake of cytosolic beta-alanine in human cells is inferred from the corresponding process known to occur in rat (Tamaki et al. 2000).
R-HSA-909776 (Reactome) Mitochondrial AGXT2 tetramer catalyzes the reaction of beta-alanine and pyruvate to form 3-oxopropanoate and alanine. While the human mitochondrial AGXT2 enzyme has been characterized experimentally in other respects (Rodionov et al. 2010), its ability to catalyze this transamination reaction is inferred from the properties of its rat homologue.
R-HSA-909780 (Reactome) Mitochondrial AGXT2 tetramer catalyzes the reaction of (R)-3-aminoisobutyric acid and pyruvate to form 2-methyl-3-oxopropanoate and alanine. While the human mitochondrial AGXT2 enzyme has been characterized experimentally in other respects (Rodionov et al. 2010), its ability to catalyze this transamination reaction is inferred from the properties of its rat homologue.
R1P, dRibPArrowR-HSA-74242 (Reactome)
R1P, dRibPArrowR-HSA-74249 (Reactome)
R1P, dRibPArrowR-HSA-74376 (Reactome)
R5PArrowR-HSA-2393939 (Reactome)
R5PArrowR-HSA-2393954 (Reactome)
R5PArrowR-HSA-5696049 (Reactome)
SAMHD1:Zn2+ tetramermim-catalysisR-HSA-8866601 (Reactome)
TMP, U2MP, U3MP, UMP, dU3MP, dUMPR-HSA-109480 (Reactome)
TMP, UMP, dU5MP, U2MP, U3MPR-HSA-109514 (Reactome)
TYMP dimermim-catalysisR-HSA-112265 (Reactome)
Thy, UraArrowR-HSA-112265 (Reactome)
Thy-Rib, (d)UArrowR-HSA-109480 (Reactome)
Thy-Rib, dUR-HSA-112265 (Reactome)
Thy-dRib, Ura-Rib, dUArrowR-HSA-109514 (Reactome)
ThyR-HSA-73616 (Reactome)
UDP,GDP,CDP,dTDPArrowR-HSA-8851234 (Reactome)
UDP,GDP,CDP,dTDPR-HSA-8851225 (Reactome)
UIBAArrowR-HSA-73618 (Reactome)
UIBAR-HSA-73620 (Reactome)
UMP,GMP,CMP,dTMPArrowR-HSA-8851225 (Reactome)
UPB1:Zn2+mim-catalysisR-HSA-73591 (Reactome)
UPB1:Zn2+mim-catalysisR-HSA-73620 (Reactome)
UPP1, UPP2mim-catalysisR-HSA-74376 (Reactome)
UPROPArrowR-HSA-73589 (Reactome)
UPROPR-HSA-73591 (Reactome)
UTP,GTP,CTP,dTTPR-HSA-8851234 (Reactome)
UraArrowR-HSA-74376 (Reactome)
UraR-HSA-73585 (Reactome)
XANArrowR-HSA-74247 (Reactome)
XANArrowR-HSA-74255 (Reactome)
XANR-HSA-74258 (Reactome)
XDH dimermim-catalysisR-HSA-74247 (Reactome)
XDH dimermim-catalysisR-HSA-74258 (Reactome)
XMPArrowR-HSA-2509831 (Reactome)
XTPR-HSA-2509831 (Reactome)
b-AlaArrowR-HSA-73591 (Reactome)
b-AlaArrowR-HSA-909765 (Reactome)
b-AlaR-HSA-909765 (Reactome)
b-AlaR-HSA-909776 (Reactome)
dGMPR-HSA-8953339 (Reactome)
dGTPArrowR-HSA-8866601 (Reactome)
dIDPR-HSA-2509793 (Reactome)
dIMPArrowR-HSA-2509793 (Reactome)
dIMPArrowR-HSA-2509838 (Reactome)
dITPR-HSA-2509838 (Reactome)
dNTP(4-)R-HSA-8866601 (Reactome)
dRibPArrowR-HSA-112265 (Reactome)
urateArrowR-HSA-74258 (Reactome)

Personal tools